Bracco Diagnostics, Inc has been given the go ahead by the U.S. Food and Drug Administration to temporarily import Iomeron (iomeprol injection) into the U.S. market amid the ongoing iodinated contrast media shortage.
Elucid's AI analysis software in action. The left image shows coronary CT angiography of a vessel showing plaque heavy calcium burden. The right image, processed by Elucid's software, highlights the various types of plaque morphology of these lesions.
New artificial intelligence software that can evaluate coronary CT scans to automatically assess soft plaques were by far the biggest technology advance discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting.
Example of various breast MRI protocol sequences that offer different types of soft tissue enhancement. Breast MRI can help see through dense breast tissue to better detect cancers. Imaging performed on a Siemens Magnetom system.
Experts found that although abbreviated protocols increased the amount of possible scans per hour from 4.7 to 18.8, non-scanning time rose from 50% to 74%.
Contrast being loaded into an injector for a cardiac CT scan at Duly Health and Care in Lisle, Illinois. Photo by Dave Fornell
“For patients with a prior ICM-induced hypersensitivity reaction, healthcare providers must balance the benefit of ICM reuse against the risk of a repeat reaction,” authors of a new meta-analysis published in Radiology said.
A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.
Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shared his key takeaways from the SCCT 2022 conference.
In the largest known study to date on the relationship between moderate alcohol consumption and iron homeostasis, experts suggested that as little as four drinks per week can increase the presence of iron deposits on imaging.
On July 18 Fresenius Kabi announced that they are rolling out a line of generic contrast media products, starting immediately with Iodixanol Injection USP.
